1.14.20.13	(1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane	slight inhibition by the substrate analogue	89457	
1.14.20.13	1-methylpiperidin-4-yl 2-phenylacetate	-	192681	
1.14.20.13	3,4-dihydroxybenzoate	competitive inhibitor with respect to 2-oxoglutarate	736	
1.14.20.13	6,7-Dehydrohyoscyamine	-	29621	
1.14.20.13	8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-(dimethylamino)phenyl)acetate	-	175469	
1.14.20.13	8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylpropanoate	-	193168	
1.14.20.13	8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate	-	175470	
1.14.20.13	8-oxabicyclo[3.2.1]octan-3-yl 2-phenylacetate	-	193169	
1.14.20.13	Ca2+	5 mM, 100% inhibition	15	
1.14.20.13	Cd2+	0.4 mM, 100% inhibition	52	
1.14.20.13	Co2+	0.4 mM, 100% inhibition	23	
1.14.20.13	Cu2+	0.4 mM, 100% inhibition	19	
1.14.20.13	Cu2+	5 mM, 100% inhibition	19	
1.14.20.13	CuSO4	100% inhibition	263	
1.14.20.13	EDTA	0.1 mM, 67% inhibition	21	
1.14.20.13	EDTA	5 mM, 61% inhibition	21	
1.14.20.13	Fe3+	5 mM, 65% inhibition	70	
1.14.20.13	Hg2+	0.4 mM, 96% inhibition	33	
1.14.20.13	Mg2+	5 mM, 14% inhibition	6	
1.14.20.13	MgSO4	24% inhibition	1205	
1.14.20.13	Mn2+	0.4 mM, 95% inhibition	11	
1.14.20.13	MnSO4	100% inhibition	1722	
1.14.20.13	additional information	no marked effect on enzyme activity by addition of NAD+, NADH, NADP+, NADPH, ATP + MgSO4, FAD, FMN, pyrroloquinoline quinone, acetyl-CoA, 6,7-dimethyl-5,6,7,8-tetrahydrofolate, phenazine methosulfate, 2,6-dichlorophenolindophenol, cytochrome c and H2O2	2	
1.14.20.13	additional information	synthesis and inhibitory potencies of substrate analogues, overview. No inhibition by substrate analogues 1-methylpiperidin-4-yl 2-phenylacetate, 8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylpropanoate, and 8-oxabicyclo[3.2.1]octan-3-yl 2-phenylacetate	2	
1.14.20.13	Ni2+	0.4 mM, 96% inhibition	38	
1.14.20.13	Ni2+	5 mM, 64% inhibition	38	
1.14.20.13	nitroblue tetrazolium	-	2573	
1.14.20.13	Pyridine 2,4-dicarboxylate	-	1592	
1.14.20.13	Pyridine 2,4-dicarboxylate	competitive inhibitor with respect to 2-oxoglutarate	1592	
1.14.20.13	Tiron	-	1881	
1.14.20.13	Zn2+	0.4 mM, 100% inhibition	14	
1.14.20.13	Zn2+	5 mM, 66% inhibition	14	
1.14.20.13	ZnSO4	100% inhibition	485